Table 2.
CpG | Gene | rsID | SNP Position (hg38 Chr:bp) | A1/A2 | βmeQTL | PmeQTL | βEWAS | P EWAS | OR | P | PRECISESADSSADs |
---|---|---|---|---|---|---|---|---|---|---|---|
A. Genetic effects on SS mediated by changes in DNA methylation | |||||||||||
cg08099136 | PSMB8 | rs9275569 | 6:32,710,259 | C/T | − 0.018 | 1.92 × 10−04 | − 0.062 | 2.43 × 10–09 | 2.03 | 1.57 × 10−08 | SLE (1 x 10–04) |
cg14880222 | IFI44 | rs1051047* | 1:78,663,909 | A/G | 0.027 | 5.94 × 10−08 | − 0.036 | 3.61 × 10–09 | 0.54 | 0.0127 | SLE (0.042) |
cg03879629 | intergenic (CCR cluster) | rs9838739* | 3:46,095,597 | T/C | − 0.046 | 5.21 × 10−05 | − 0.071 | 7.81 × 10–09 | 1.71 | 0.0242 | SLE (0.002), MCTD (0.008), UCTD (0.004) |
cg12013713 | PARP12 | rs6962291*# | 7:139,971,218 | T/A | − 0.017 | 2.96 × 10−05 | − 0.048 | 8.54 × 10–09 | 1.32 | 0.0270 |
Transcript | Gene | rsID | SNP Position (hg38 Chr:bp) | A1/A2 | βeQTL | PeQTL | βdiffexp | P diffexp | OR | P | PRECISESADS |
---|---|---|---|---|---|---|---|---|---|---|---|
B.Genetic effects on SS mediated by changes in gene expression | |||||||||||
ENSG00000166278 | C2 | rs1054684$# | 6:32,809,044 | T/C | 0.300 | 3.57 × 10−04 | 0.911 | 1.46 × 10−13 | 4.04 | 2.16 × 10−13 | SLE(1 x 10–05), MCTD (0.03), UCTD (0.048) |
ENSG00000204267 | TAP2 | rs4947258 | 6:32,779,625 | A/G | 0.168 | 3.51 × 10−04 | 0.478 | 2.31 × 10−17 | 3.53 | 2.90 × 10−12 | SLE(1 x 10–05) |
ENSG00000240065 | PSMB9 | rs3117106 | 6:32,375,492 | T/C | 0.139 | 2.19 × 10−04 | 0.287 | 1.12 × 10−08 | 2.22 | 1.23 × 10−07 | SLE (0.001) |
ENSG00000204713 | TRIM27 | rs2523425* | 6:29,526,364 | C/T | − 0.069 | 9.24 × 10−06 | − 0.136 | 1.06 × 10−06 | 1.51 | 7.32 × 10−04 | SADSnoSS (0.03) |
ENSG00000128604 | IRF5 | rs4731531$* | 7:128,922,493 | G/A | 0.084 | 3.45 × 10−04 | 0.192 | 6.48 × 10−07 | 1.46 | 0.0014 | SLE (0.005) |
ENSG00000174444 | RPL4 | rs4482223 | 15:65,828,392 | A/G | 0.101 | 3.18 × 10−04 | − 0.195 | 1.01 × 10−09 | 0.53 | 0.0019 | RA (0.004) |
ENSG00000124508 | BTN2A2 | rs3799378*# | 6:26,404,046 | A/G | 0.096 | 2.74 × 10−04 | 0.228 | 4.61 × 10−08 | 1.54 | 0.0025 | |
ENSG00000234127 | TRIM26 | rs9261518 | 6:30,149,108 | G/A | − 0.113 | 2.66 × 10−05 | 0.154 | 3.65 × 10−09 | 0.60 | 0.0029 | UCTD (0.01) |
ENSG00000175970 | UNC119B | rs10849822* | 12:120,939,591 | G/C | − 0.066 | 3.28 × 10−04 | − 0.161 | 2.88 × 10−09 | 1.48 | 0.0075 | SLE (0.02) |
ENSG00000162614 | NEXN | rs6660288 | 1:78,927,603 | G/A | 0.143 | 2.73 × 10−04 | 0.685 | 3.02 × 10−14 | 1.36 | 0.0156 | MCTD (0.04), UCTD (0.02) |
ENSG00000002549 | LAP3 | rs57570581 | 4:17,705,638 | G/A | − 0.216 | 2.76 × 10−05 | 0.867 | 2.61 × 10−22 | 0.75 | 0.0187 | UCTD (0.02) |
ENSG00000204516 | MICB | rs9348883# | 6:32,390,672 | T/A | − 0.174 | 3.12 × 10−04 | 0.242 | 1.19 × 10−09 | 0.46 | 0.0276 | |
ENSG00000154451 | GBP5 | rs76397273* | 1:89,333,021 | A/G | − 0.288 | 9.70 × 10−05 | 0.701 | 2.54 × 10−13 | 0.67 | 0.0301 | SSc (0.007), UCTD (0.03) |
ENSG00000184898 | RBM43 | rs289953 | 2:151,143,385 | T/C | 0.183 | 8.55 × 10−09 | 0.378 | 5.03 × 10−12 | 1.29 | 0.0398 | SLE (0.03), SSc (0.01) |
ENSG00000166750 | SLFN5 | rs11080327* | 17:35,244,427 | G/A | 0.222 | 4.68 × 10−14 | 0.255 | 1.11 × 10−06 | 1.28 | 0.0401 | PAPs (0.04) |
Alleles represent major allele first, and then the minor allele, which is the allele tested in each analysis.
β meQTL represents the DNA methylation change with the increased in dosage of the minor allele.
P meQTL corresponds to the P value from the linear regression model that regresses out the number of minor alleles for a given SNP to DNA methylation levels adjusting by age, sex, batch effects, estimated cell proportions, disease status and first genetic component.
βEWAS represents the DNA methylation difference between SS and healthy controls from the epigenome-wide association study together obtained by linear regression model in which DNA methylation levels are regressed out by SS status and adjusted by age, sex, batch effects and estimated cell proportions.
OR represents the Odd Ratio obtained from genetic association testing based on logistic regression modeling which the SS statuts is regressed out by number of minor alleles for a given SNP adjusted by age, sex, batch effects, estimated cell proportions and first genetic component and its corresponding.
P represents the P-value obtained in the genetic associations.
SAD (OR, P) represents the odd ratio and P value obtained in genetic testing for other diseases. RA = Rheumatoid Arthritis, SLE = Systemic Lupus Erythemathosus, UCTD = Undifferentiated Connective Tissue Disease, SSc = Systemic Scleroderma, PAPs = Primary anti-phospholipid syndrome. SADSnoSS = All SADs patients excluding SS.
Genomic positions are based on the hg19 human reference sequence build (GRCh37).
* eQTL reported in GTEx project (https://www.gtexportal.org/home/), in the case of eQTL the same SNP-gene is reported.
# SNP associated with related disease phenotype in GWAS catalog (https://www.ebi.ac.uk/gwas/) or Open Target Genetics Portal (https://genetics.opentargets.org/).